New delivery method for liver cancer radiation therapy
Part of Cancer clinical trials.
This trial tests a special catheter (TriNav) to deliver radiation directly to liver tumors. It aims to improve targeting and reduce side effects for people with liver cancer that cannot be surgically removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older with liver cancer that cannot be surgically removed
- Your cancer has spread from another part of the body or started in the liver
- You are eligible for a type of internal radiation therapy called Y90-radioembolization
- You can care for yourself (ECOG score 0-2) and are expected to live at least 3 months
- You have at least one liver tumor that is 1.2 inches (3 cm) or larger
- You do not have tumors that grow in a scattered, infiltrative pattern
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of delivering tiny radioactive beads (called Y-90 microspheres) directly to liver tumors. One method uses a standard catheter, while the other uses a special catheter that controls pressure to deliver the beads more precisely. The goal is to see which method works better for targeting tumors while sparing healthy tissue.
This trial tests a radiation treatment called Y-90 given before liver surgery for colorectal cancer that has spread to the liver. The goal is to help the liver grow enough for safer, curative surgery, either right away or as part of a two-step operation.
This study tests a higher dose of radiation delivered directly to liver tumors through small beads. It aims to improve tumor control while keeping side effects manageable for people whose liver cancer is not removable by surgery.
This study tests a targeted radiation treatment called Y90 for liver tumors that are too large for standard approaches. It aims to see how well the treatment works for people with primary or secondary liver cancers that mainly affect the liver and have at least one tumor bigger than 5 cm.
This trial tests a treatment called yttrium-90 radioembolization (tiny radioactive beads delivered to the liver) for people with liver cancer that has already been treated before. The goal is to see if it can help control the tumor when other treatments haven't been enough.
This trial tests a combination of treatments for liver cancer that cannot be removed by surgery. It uses a special radiation therapy called Y90 along with other drugs to see if they work better together.
Hear when a new Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.